Company Search:
Advanced Search
Sponsored Links
Pharmaxis Ltd - ADR Company Snapshot
Pharmaxis Ltd operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pharmaxis Ltd with three other companies in this sector in the United States: Immune Design Corp (2016 sales of $13.26 million of which 100% was Pharmaceutical), Voyager Therapeutics Inc ($14.22 million ), and Cytomx Therapeutics Inc ($15.04 million of which 100% was Pharmaceutical).

Sales Analysis. Sales fell dramatically in 2016: During the year ended June of 2016, sales at Pharmaxis Ltd were $13.50 million. This is a sharp decrease of 72.2% versus 2015, when the company's sales were $48.51 million. Contributing to the drop in overall sales was the 94.4% decline in New Drug Development, from $33.60 million to $1.88 million. There were also decreases in sales in Bronchitol and Aridol (down 25.3% to $10.84 million) and Corporate (down 27.1% to $230,484.36 ) .
  Stock Performance Chart for Pharmaxis Ltd - ADR
  Stock Data: Recent Stock Performance:
  Current Price (6/28/2017): 2.57
(Figures in U.S. Dollars)
1 Week n/a   13 Weeks n/a  
4 Weeks n/a   52 Weeks n/a  
Pharmaxis Ltd - ADR Key Data:
  Ticker: PXSLY Country: United States
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 13,504,057
(Year Ending Jan 2017).
Employees: 107
  Currency: U.S. Dollars Market Cap: 54,605,106
  Fiscal Yr Ends: June Shares Outstanding: 21,247,123
  Share Type: Ordinary Closely Held Shares: 3,144,730
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.